Major Estimate Revision • Jun 12
Consensus EPS estimates increase by 121% The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from CN¥23.4b to CN¥25.3b. EPS estimate increased from CN¥0.238 to CN¥0.527 per share. Net income forecast to grow 76% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target up from CN¥11.06 to CN¥15.07. Share price was steady at CN¥13.62 over the past week. New Risk • May 04
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (15% operating cash flow to total debt). Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Large one-off items impacting financial results. Reported Earnings • May 01
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: EPS: CN¥0.21 (up from CN¥0.17 loss in FY 2024). Revenue: CN¥21.6b (up 16% from FY 2024). Net income: CN¥457.9m (up CN¥825.1m from FY 2024). Profit margin: 2.1% (up from net loss in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 31%. Revenue is forecast to stay flat during the next 3 years compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 109 percentage points per year, which is a significant difference in performance. Ankündigung • Apr 30
Ningbo Shanshan Co.,Ltd., Annual General Meeting, May 20, 2026 Ningbo Shanshan Co.,Ltd., Annual General Meeting, May 20, 2026, at 13:30 China Standard Time. Location: 28F, No. 777, Rili Middle Road, Yinzhou District, Ningbo, Zhejiang China Ankündigung • Mar 30
Ningbo Shanshan Co.,Ltd. to Report Q1, 2026 Results on Apr 30, 2026 Ningbo Shanshan Co.,Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026 Ankündigung • Dec 26
Ningbo Shanshan Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 30, 2026 Ningbo Shanshan Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 30, 2026 New Risk • Nov 04
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 1.7x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.7x net interest cover). Minor Risk Share price has been volatile over the past 3 months (8.4% average weekly change). Reported Earnings • Oct 31
Third quarter 2025 earnings released: EPS: CN¥0.036 (vs CN¥0.003 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.036 (up from CN¥0.003 in 3Q 2024). Revenue: CN¥4.95b (up 11% from 3Q 2024). Net income: CN¥76.3m (up CN¥70.7m from 3Q 2024). Profit margin: 1.5% (up from 0.1% in 3Q 2024). Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance. Buy Or Sell Opportunity • Oct 17
Now 22% undervalued Over the last 90 days, the stock has risen 30% to CN¥12.40. The fair value is estimated to be CN¥15.87, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.0% over the last 3 years. Meanwhile, the company became loss making. New Risk • Oct 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.6x net interest cover). Minor Risk Share price has been volatile over the past 3 months (7.4% average weekly change). Ankündigung • Sep 30
Ningbo Shanshan Co.,Ltd. to Report Q3, 2025 Results on Oct 31, 2025 Ningbo Shanshan Co.,Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025 New Risk • Sep 13
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 1.7x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. This is currently the only risk that has been identified for the company. Price Target Changed • Sep 01
Price target increased by 15% to CN¥11.54 Up from CN¥10.00, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of CN¥11.61. Stock is up 66% over the past year. The company is forecast to post earnings per share of CN¥0.65 next year compared to a net loss per share of CN¥0.17 last year. Buy Or Sell Opportunity • Aug 13
Now 20% undervalued Over the last 90 days, the stock has risen 55% to CN¥11.64. The fair value is estimated to be CN¥14.61, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.1% over the last 3 years. Meanwhile, the company became loss making. Ankündigung • Jun 30
Ningbo Shanshan Co.,Ltd. to Report First Half, 2025 Results on Aug 30, 2025 Ningbo Shanshan Co.,Ltd. announced that they will report first half, 2025 results on Aug 30, 2025 Reported Earnings • Apr 28
First quarter 2025 earnings released: EPS: CN¥0.015 (vs CN¥0.033 loss in 1Q 2024) First quarter 2025 results: EPS: CN¥0.015 (up from CN¥0.033 loss in 1Q 2024). Revenue: CN¥4.80b (up 28% from 1Q 2024). Net income: CN¥33.1m (up CN¥106.4m from 1Q 2024). Profit margin: 0.7% (up from net loss in 1Q 2024). Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance. Ankündigung • Apr 26
Ningbo Shanshan Co.,Ltd., Annual General Meeting, May 16, 2025 Ningbo Shanshan Co.,Ltd., Annual General Meeting, May 16, 2025, at 13:30 China Standard Time. Location: 28F, No. 777, Rili Middle Road, Yinzhou District, Ningbo, Zhejiang China Ankündigung • Mar 28
Ningbo Shanshan Co.,Ltd. to Report Q1, 2025 Results on Apr 26, 2025 Ningbo Shanshan Co.,Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025 Ankündigung • Dec 27
Ningbo Shanshan Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025 Ningbo Shanshan Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025 Reported Earnings • Oct 31
Third quarter 2024 earnings released: EPS: CN¥0.003 (vs CN¥0.11 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.003 (down from CN¥0.11 in 3Q 2023). Revenue: CN¥4.46b (down 15% from 3Q 2023). Net income: CN¥5.64m (down 97% from 3Q 2023). Profit margin: 0.1% (down from 3.6% in 3Q 2023). Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 35 percentage points per year, which is a significant difference in performance. Ankündigung • Sep 30
Ningbo Shanshan Co.,Ltd. to Report Q3, 2024 Results on Oct 31, 2024 Ningbo Shanshan Co.,Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024 Reported Earnings • Aug 31
Second quarter 2024 earnings released: EPS: CN¥0.042 (vs CN¥0.25 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.042 (down from CN¥0.25 in 2Q 2023). Revenue: CN¥5.07b (up 1.0% from 2Q 2023). Net income: CN¥90.9m (down 79% from 2Q 2023). Profit margin: 1.8% (down from 8.8% in 2Q 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 38% per year, which means it has not declined as severely as earnings. Ankündigung • Jun 28
Ningbo Shanshan Co.,Ltd. to Report First Half, 2024 Results on Aug 30, 2024 Ningbo Shanshan Co.,Ltd. announced that they will report first half, 2024 results on Aug 30, 2024 Price Target Changed • Jun 19
Price target decreased by 9.0% to CN¥12.61 Down from CN¥13.86, the current price target is an average from 3 analysts. New target price is 30% above last closing price of CN¥9.67. Stock is down 34% over the past year. The company is forecast to post earnings per share of CN¥0.88 for next year compared to CN¥0.35 last year. Ankündigung • Jun 08
Ningbo Shanshan Co.,Ltd. (SHSE:600884) announces an Equity Buyback for CNY 400 million worth of its shares. Ningbo Shanshan Co.,Ltd. (SHSE:600884) announces a share repurchase program. Under the program, the company will repurchase up to CNY 400 million worth of its shares. The shares will be purchased at a price not exceeding CNY 16.60 per share. The purpose of the program is to protect the company's value and shareholders' rights. The repurchased shares will be sold in accordance with relevant regulations, and the part that is not sold after the deadline will be cancelled according to law.. The program will be valid for 3 months. Declared Dividend • Jun 03
Dividend reduced to CN¥0.20 Dividend of CN¥0.20 is 33% lower than last year. Ex-date: 6th June 2024 Payment date: 6th June 2024 Dividend yield will be 2.0%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is not covered by earnings (382% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 25% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 325% to bring the payout ratio under control. EPS is expected to grow by 224% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio. Major Estimate Revision • May 02
Consensus revenue estimates fall by 18% The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥26.8b to CN¥22.0b. EPS estimate fell from CN¥0.967 to CN¥0.476 per share. Net income forecast to grow 965% next year vs 60% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥13.83. Share price rose 6.6% to CN¥11.85 over the past week. Reported Earnings • Apr 27
First quarter 2024 earnings released: CN¥0.033 loss per share (vs CN¥0.29 profit in 1Q 2023) First quarter 2024 results: CN¥0.033 loss per share (down from CN¥0.29 profit in 1Q 2023). Revenue: CN¥3.75b (down 16% from 1Q 2023). Net loss: CN¥73.3m (down 113% from profit in 1Q 2023). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings. Ankündigung • Apr 27
Ningbo Shanshan Co.,Ltd., Annual General Meeting, May 16, 2024 Ningbo Shanshan Co.,Ltd., Annual General Meeting, May 16, 2024, at 13:30 China Standard Time. Location: 28F, No. 777, Rili Middle Road, Yinzhou District, Ningbo, Zhejiang China Ankündigung • Mar 30
Ningbo Shanshan Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024 Ningbo Shanshan Co.,Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024 Major Estimate Revision • Feb 26
Consensus EPS estimates fall by 48% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥24.0b to CN¥22.9b. EPS estimate also fell from CN¥0.867 per share to CN¥0.45 per share. Net income forecast to grow 26% next year vs 58% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥14.20. Share price was steady at CN¥11.31 over the past week. Ankündigung • Feb 07
Ningbo Shanshan Co.,Ltd. (SHSE:600884) announces an Equity Buyback for CNY 500 million worth of its shares. Ningbo Shanshan Co.,Ltd. (SHSE:600884) announces a share repurchase program. Under the program, the company will repurchase up to CNY 500 million worth of its shares. The shares will be purchased at a price not exceeding CNY 18.60 per share. The purpose of the program is to maintain the company’s value and safeguard the rights and interests of shareholders. The program will be valid for 3 months. Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to CN¥9.40, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 37% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.01 per share. Ankündigung • Dec 30
Ningbo Shanshan Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024 Ningbo Shanshan Co.,Ltd. announced that they will report fiscal year 2023 results on Apr 26, 2024 Reported Earnings • Nov 02
Third quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.25 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.11 (down from CN¥0.25 in 3Q 2022). Revenue: CN¥5.24b (up 3.4% from 3Q 2022). Net income: CN¥189.1m (down 66% from 3Q 2022). Profit margin: 3.6% (down from 11% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. Board Change • Oct 18
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 10 experienced directors. 1 highly experienced director. 4 independent directors (5 non-independent directors). Independent director Yan Xiu Xu was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Price Target Changed • Sep 08
Price target decreased by 10% to CN¥16.36 Down from CN¥18.25, the current price target is an average from 5 analysts. New target price is 13% above last closing price of CN¥14.53. Stock is down 41% over the past year. The company is forecast to post earnings per share of CN¥1.01 for next year compared to CN¥1.23 last year. Reported Earnings • Aug 30
Second quarter 2023 earnings released: EPS: CN¥0.25 (vs CN¥0.40 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.25 (down from CN¥0.40 in 2Q 2022). Revenue: CN¥5.02b (down 13% from 2Q 2022). Net income: CN¥440.5m (down 48% from 2Q 2022). Profit margin: 8.8% (down from 15% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Price Target Changed • Jun 07
Price target decreased by 8.7% to CN¥21.00 Down from CN¥23.00, the current price target is an average from 6 analysts. New target price is 42% above last closing price of CN¥14.75. Stock is down 39% over the past year. The company is forecast to post earnings per share of CN¥1.29 for next year compared to CN¥1.23 last year. Major Estimate Revision • May 12
Consensus EPS estimates fall by 14%, revenue upgraded The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from CN¥23.0b to CN¥25.1b. EPS estimate fell from CN¥1.50 to CN¥1.29 per share. Net income forecast to grow 23% next year vs 55% growth forecast for Chemicals industry in China. Consensus price target of CN¥22.67 unchanged from last update. Share price rose 2.3% to CN¥15.37 over the past week. Reported Earnings • Apr 24
Full year 2022 earnings: EPS misses analyst expectations Full year 2022 results: EPS: CN¥1.23 (down from CN¥2.04 in FY 2021). Revenue: CN¥21.7b (up 4.8% from FY 2021). Net income: CN¥2.69b (down 19% from FY 2021). Profit margin: 12% (down from 16% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 4.0%. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth. Major Estimate Revision • Apr 22
Consensus revenue estimates fall by 12% The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥26.2b to CN¥22.9b. EPS estimate fell from CN¥1.63 to CN¥1.36 per share. Net income forecast to shrink 11% next year vs 38% growth forecast for Chemicals industry in China . Consensus price target down from CN¥23.00 to CN¥22.20. Share price fell 2.9% to CN¥16.33 over the past week. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. 5 independent directors (7 non-independent directors). Vice Chairman Wei Zhuang was the last director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Oct 28
Third quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥1.22 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.25 (down from CN¥1.22 in 3Q 2021). Revenue: CN¥5.07b (down 12% from 3Q 2021). Net income: CN¥547.7m (down 73% from 3Q 2021). Profit margin: 11% (down from 35% in 3Q 2021). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth. Price Target Changed • Oct 24
Price target decreased to CN¥27.60 Down from CN¥30.20, the current price target is an average from 5 analysts. New target price is 39% above last closing price of CN¥19.85. Stock is down 51% over the past year. The company is forecast to post earnings per share of CN¥1.38 for next year compared to CN¥2.04 last year. Reported Earnings • Aug 12
Second quarter 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.28 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.40 (up from CN¥0.28 in 2Q 2021). Revenue: CN¥5.74b (down 3.4% from 2Q 2021). Net income: CN¥854.1m (up 87% from 2Q 2021). Profit margin: 15% (up from 7.7% in 2Q 2021). The increase in margin was driven by lower expenses. Over the next year, revenue is forecast to grow 15%, compared to a 41% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 91% per year but the company’s share price has only increased by 59% per year, which means it is significantly lagging earnings growth. Ankündigung • Jul 26
Ningbo Shanshan Co.,Ltd. has completed a Follow-on Equity Offering in the amount of $318.729072 million. Ningbo Shanshan Co.,Ltd. has completed a Follow-on Equity Offering in the amount of $318.729072 million.
Security Name: Gloabal Deposotory Reciepts
Security Type: Common Stock
Securities Offered: 15,442,300
Price\Range: $20.64
Transaction Features: New Market Listing Valuation Update With 7 Day Price Move • Jun 28
Investor sentiment improved over the past week After last week's 21% share price gain to CN¥31.80, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 312% over the past three years. Major Estimate Revision • May 10
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 EPS estimate fell from CN¥1.42 to CN¥1.22 per share. Revenue forecast steady at CN¥21.8b. Net income forecast to shrink 17% next year vs 39% growth forecast for Chemicals industry in China . Consensus price target down from CN¥31.58 to CN¥30.18. Share price fell 3.2% to CN¥21.45 over the past week. Reported Earnings • Apr 28
First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind First quarter 2022 results: EPS: CN¥0.38 (up from CN¥0.19 in 1Q 2021). Revenue: CN¥5.03b (up 26% from 1Q 2021). Net income: CN¥807.1m (up 167% from 1Q 2021). Profit margin: 16% (up from 7.6% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 7.8%. Earnings per share (EPS) exceeded analyst estimates by 57%. Over the next year, revenue is forecast to grow 5.9%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth. Major Estimate Revision • Apr 27
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast fell from CN¥25.6b to CN¥21.6b. EPS estimate increased from CN¥1.12 to CN¥1.42 per share. Net income forecast to shrink 9.1% next year vs 41% growth forecast for Chemicals industry in China . Consensus price target down from CN¥34.48 to CN¥31.58. Share price fell 14% to CN¥21.52 over the past week. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. 4 highly experienced directors. 3 independent directors (7 non-independent directors). Director Guanghua Chen was the last director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Apr 21
Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2021 results: EPS: CN¥2.04 (up from CN¥0.097 in FY 2020). Revenue: CN¥20.7b (up 152% from FY 2020). Net income: CN¥3.34b (up CN¥3.20b from FY 2020). Profit margin: 16% (up from 1.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 7.8%. Earnings per share (EPS) exceeded analyst estimates by 57%. Over the next year, revenue is forecast to grow 4.6%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth. Price Target Changed • Apr 20
Price target decreased to CN¥32.58 Down from CN¥36.68, the current price target is an average from 6 analysts. New target price is 29% above last closing price of CN¥25.16. Stock is up 69% over the past year. Price Target Changed • Jan 04
Price target increased to CN¥36.68 Up from CN¥33.47, the current price target is an average from 7 analysts. New target price is 16% above last closing price of CN¥31.67. Stock is up 78% over the past year. The company is forecast to post earnings per share of CN¥1.90 for next year compared to CN¥0.097 last year. Price Target Changed • Nov 26
Price target increased to CN¥39.42 Up from CN¥33.47, the current price target is an average from 6 analysts. New target price is 9.5% above last closing price of CN¥36.00. Stock is up 158% over the past year. The company is forecast to post earnings per share of CN¥1.90 for next year compared to CN¥0.097 last year. Reported Earnings • Oct 28
Third quarter 2021 earnings released: EPS CN¥1.22 (vs CN¥0.12 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥5.77b (up 145% from 3Q 2020). Net income: CN¥2.01b (up CN¥1.84b from 3Q 2020). Profit margin: 35% (up from 7.5% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 67% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥38.30, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 344% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥23.06 per share. Valuation Update With 7 Day Price Move • Sep 16
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥37.41, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 238% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥21.58 per share. Major Estimate Revision • Aug 16
Consensus revenue estimates increase to CN¥23.1b The consensus outlook for revenues in 2021 has improved. 2021 revenue forecast increased from CN¥20.9b to CN¥23.1b. EPS estimate increased from CN¥0.74 to CN¥1.01 per share. Net income forecast to grow 121% next year vs 42% growth forecast for Chemicals industry in China. Consensus price target up from CN¥18.66 to CN¥26.17. Share price was steady at CN¥29.57 over the past week. Reported Earnings • Aug 10
Second quarter 2021 earnings released: EPS CN¥0.28 (vs CN¥0.21 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥5.95b (up 199% from 2Q 2020). Net income: CN¥457.4m (up 149% from 2Q 2020). Profit margin: 7.7% (down from 9.2% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has increased by 35% per year, which means it is well ahead of earnings. Price Target Changed • Aug 10
Price target increased to CN¥21.66 Up from CN¥18.66, the current price target is an average from 5 analysts. New target price is 27% below last closing price of CN¥29.56. Stock is up 137% over the past year. Valuation Update With 7 Day Price Move • Jul 28
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CN¥26.69, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 117% over the past three years. Valuation Update With 7 Day Price Move • Jul 08
Investor sentiment improved over the past week After last week's 22% share price gain to CN¥27.47, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 104% over the past three years. Price Target Changed • Jun 23
Price target increased to CN¥16.06 Up from CN¥14.08, the current price target is an average from 4 analysts. New target price is 25% below last closing price of CN¥21.39. Stock is up 93% over the past year. Valuation Update With 7 Day Price Move • Jun 09
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥20.32, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 42% over the past three years. Price Target Changed • May 19
Price target increased to CN¥14.08 Up from CN¥12.54, the current price target is an average from 4 analysts. New target price is 19% below last closing price of CN¥17.38. Stock is up 121% over the past year. Major Estimate Revision • May 05
Consensus forecasts updated The consensus outlook for 2021 has been updated. 2021 revenue forecast fell from CN¥22.4b to CN¥21.1b. EPS estimate rose from CN¥0.70 to CN¥0.79. Net income forecast to grow 126% next year vs 39% growth forecast for Chemicals industry in China. Consensus price target up from CN¥12.20 to CN¥12.95. Share price rose 14% to CN¥17.00 over the past week. Reported Earnings • May 01
First quarter 2021 earnings released: EPS CN¥0.19 (vs CN¥0.052 loss in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥4.00b (up 227% from 1Q 2020). Net income: CN¥302.3m (up CN¥386.0m from 1Q 2020). Profit margin: 7.6% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings. Major Estimate Revision • Apr 10
Consensus forecasts updated The consensus outlook for 2021 has been updated. 2021 revenue forecast fell from CN¥22.6b to CN¥22.4b. EPS estimate rose from CN¥0.74 to CN¥0.88. Net income forecast to grow 934% next year vs 52% growth forecast for Chemicals industry in China. Consensus price target up from CN¥10.00 to CN¥12.20. Share price fell 3.8% to CN¥14.35 over the past week. Price Target Changed • Apr 06
Price target increased to CN¥12.20 Up from CN¥10.28, the current price target is an average from 2 analysts. New target price is 22% below last closing price of CN¥15.63. Stock is up 106% over the past year. Reported Earnings • Apr 03
Full year 2020 earnings released: EPS CN¥0.097 (vs CN¥0.17 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥8.22b (down 5.3% from FY 2019). Net income: CN¥138.0m (down 49% from FY 2019). Profit margin: 1.7% (down from 3.1% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Ankündigung • Jan 28
Ningbo Shanshan Co.,Ltd.(XSSC:600884) dropped from FTSE All-World Index (USD) Ningbo Shanshan Co.,Ltd.(XSSC:600884) dropped from FTSE All-World Index (USD) Ankündigung • Jan 22
Ningbo Shanshan Co.,Ltd. to Report Fiscal Year 2020 Results on Mar 23, 2021 Ningbo Shanshan Co.,Ltd. announced that they will report fiscal year 2020 results on Mar 23, 2021 Price Target Changed • Jan 19
Price target raised to CN¥11.48 Up from CN¥10.28, the current price target is an average from 4 analysts. The new target price is 27% below the current share price of CN¥15.65. As of last close, the stock is up 72% over the past year. Is New 90 Day High Low • Dec 25
New 90-day high: CN¥19.02 The company is up 84% from its price of CN¥10.33 on 25 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥0.90 per share. Is New 90 Day High Low • Dec 08
New 90-day high: CN¥15.63 The company is up 51% from its price of CN¥10.37 on 09 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥0.77 per share. Is New 90 Day High Low • Nov 17
New 90-day high: CN¥13.23 The company is up 2.0% from its price of CN¥12.95 on 19 August 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥0.81 per share. Reported Earnings • Oct 28
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥259.7m, down 25% from the prior year. Total revenue was CN¥7.73b over the last 12 months, down 14% from the prior year. Ankündigung • Jul 09
Ningbo Shanshan Co.,Ltd. to Report First Half, 2020 Results on Aug 25, 2020 Ningbo Shanshan Co.,Ltd. announced that they will report first half, 2020 results on Aug 25, 2020